Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ribotek Biopharmaceuticals (shandong) Co., Ltd

Clinical trials sponsored by Ribotek Biopharmaceuticals (shandong) Co., Ltd, explained in plain language.

Trials to join now! 1

New drug aims to lower dangerous fat levels in blood

Disease control Recruiting now

This study tests a new drug called RBD5044 in 40 adults with high triglycerides, a type of fat in the blood that can increase heart risk. Participants receive either the drug or a placebo twice over 12 weeks. The main goal is to see if the drug safely lowers triglyceride levels c…

Phase: PHASE2 • Sponsor: Ribotek Biopharmaceuticals (Shandong) Co., Ltd • Aim: Disease control

Last updated May 15, 2026 11:53 UTC